Your browser doesn't support javascript.
loading
Case report: EGFR-mutant lung adenocarcinoma with the TP53 and RB1 mutations showed resistance to TKI therapy.
Lu, Yiyu; Li, Zhihua; Zhu, Huawei; Zhao, Juan; Xu, Mian; Gu, Weiguang.
Afiliación
  • Lu Y; Oncology Department, Nanhai People's Hospital, Foshan, China; The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China.
  • Li Z; Oncology Department, Nanhai People's Hospital, Foshan, China; The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China.
  • Zhu H; Department of Oncology, Second Affiliated Hospital of Guangxi Medical University, Nanning, China.
  • Zhao J; Shanghai OrigiMed Co., Ltd., Shanghai, China.
  • Xu M; Shanghai OrigiMed Co., Ltd., Shanghai, China.
  • Gu W; Oncology Department, Nanhai People's Hospital, Foshan, China; The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China.
Ann Palliat Med ; 10(12): 12886-12893, 2021 Dec.
Article en En | MEDLINE | ID: mdl-35016432
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Adenocarcinoma del Pulmón / Neoplasias Pulmonares Límite: Humans Idioma: En Revista: Ann Palliat Med Año: 2021 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Adenocarcinoma del Pulmón / Neoplasias Pulmonares Límite: Humans Idioma: En Revista: Ann Palliat Med Año: 2021 Tipo del documento: Article País de afiliación: China